Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JAKMIP3 antisense RNA 1 (JAKMIP3-AS1) is a long non-coding RNA gene transcribed from chromosome 10 (reverse strand), overlapping the JAKMIP3 protein-coding locus. As an antisense RNA, it may have regulatory roles analogous to other antisense lncRNAs, such as modulating gene expression of neighboring loci, affecting chromatin state, or transcriptional interference, but no specific function or disease relevance has been determined for JAKMIP3-AS1 in humans. There are no associations with druggability or clinical utility as of September 2025.
None (no mechanisms of action described for drug targeting JAKMIP3-AS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JAKMIP3 antisense RNA 1 (JAKMIP3-AS1).